Contact the dangerous drug lawyers at Mike Brandner Injury Attorneys, if you were after taking Invokana or a similar diabetes medication. Our firm is investigating a possible link between these types of medication and ketoacidosis and possible kidney failure. You may be eligible for compensation and other damages related to your injuries.
Fill out our free case evaluation form or call 952-200-3129 today.
Ketoacidosis and SGLT2 Inhibitors
Kidney health is critical for diabetic patients because they are already at risk of reduced kidney function.
Invokana® is a prescription medicine used along with diet and exercise to lower blood sugar in adults with type 2 diabetes. Invokana and other SGLT2 inhibitors work by adjusting the normal functionality of the kidneys, allowing sugar to be excreted through the patient’s urine.
However, the inhibition of the kidneys creates a high level of acid in the blood, knows as ketoacidosis.
What is ketoacidosis?
Ketoacidosis occurs when your body can’t use glucose properly and starts to burn fat for energy instead. If that goes on for too long, the acid levels in your blood skyrocket resulting in a diabetic coma or death.
Some symptoms of ketoacidosis include:
- Difficulty breathing
- Vomiting and nausea
- Abdominal pain
- Changes in urination
Our attorneys are investigating cases where patients with type 2 diabetes developed serious side effects after being prescribed SGLT2 inhibitors such as Invokana, Invokamet, Farxiga, Xigduo, Jardiance, and Glyxambi.
It’s important to remember that all the aforementioned drugs can trigger ketoacidosis. Other troubling side effects associated with SGLT Inhibitors include dehydration, kidney problems, low blood sugar when combined with other prescription medicines used to treat diabetes, increased cholesterol in the blood, and yeast infection.
FDA Safety Warning
Marketed as one of the first medications available that could help people with type 2 diabetes avoid high blood-sugar levels, it was released in 2013 by pharmaceutical giant Johnson & Johnson.
However, on May 15, 2015, the Food and Drug Administration (FDA) issued a warning that Invokana and other SGLT2 inhibitors may lead to life-threatening side effects, including:
- Kidney failure
- Kidney stones
- Urinary tract infections
- Heart attack
The agency advises anyone suffering from these side effects to seek medical attention, immediately.
Difference between Type 1 and Type 2 diabetes
The medical findings surrounding these drugs are quite significant when you consider that the Centers for Disease Control (CDC) and Prevention estimates that there are 29.1 million total diabetics in the United States.
A frequently asked question is what is the difference between Type 1 and Type 2 diabetes?
- Type 1 Diabetes is a disorder in which the body does not produce insulin (a hormone that aids in moving sugar from the blood to the cells).
- Type 2 Diabetes occurs when insulin that the body produces is less efficient at moving sugar out of the bloodstream. Some sugar moves out of the blood; just not as effectively compared to a person with normal insulin efficiency.
When left untreated, type 2 diabetes can lead to serious problems; including, but not limited to stroke, kidney failure and blindness.
A Track Record You Can Trust
In light of the potential dangers surrounding Invokana and similar medications, our lawyers want to help you and your loved ones seek justice. You may be able to recover compensation for your injuries, medical bills and other damages, but you must act now. The law may limit the time you have to file a claim.
At Mike Brandner Injury Attorneys we believe in holding pharmaceutical companies responsible for making these defective drugs. We have built a reputation of legal excellence, so let us put our experience and success to work for you.